Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed May 9, 2013 · 10-Q · 39 days after period end · 0001193125-13-211458
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Net Income | -$42.08M | -$17.70M | $1.83M |
| EPS Diluted | -$1.32 | -$0.78 | $0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 9, 2013 · 39 d after period end
